Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Harris

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Clinical Genetics|June 2, 2007
A genome-wide linkage scan for iron phenotype quantitative trait loci: the HEIRS Family StudyR T Acton, B M Snively, J C Barton, et al.
British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Clinical Genetics|June 2, 2007
A genome-wide linkage scan for iron phenotype quantitative trait loci: the HEIRS Family StudyR T Acton, B M Snively, J C Barton, et al.
British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Pageof 8